Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer Posted by By Mourabit Halima 2025.07.01
Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer Posted by By Mourabit Halima 2025.07.01
Early research, clinical practice and thinking of innovative NK cell therapy Posted by By Mourabit Halima 2025.07.01
Research Progress of Artificial Intelligence in the Field of Digestive System Tumors Posted by By Mourabit Halima 2025.07.01
From Pursuing Surgical Techniques to Changing Treatment Models: Twenty Years of Exploration Leading to Standardized Diagnosis and Treatment of Esophageal Cancer Posted by By Mourabit Halima 2025.06.30
Future Directions of Targeted Therapy for Colorectal Cancer from Perspective of New Drug Development Posted by By Mourabit Halima 2025.06.30
ASCO 2025 Researcher Insights | Prof. Dickon Hayne Presents ANZUP 1301 Study Addressing the Global BCG Shortage Posted by By Mourabit Halima 2025.06.30
PI Panel: Integrating Eastern and Western Perspectives — Future Innovations in Esophageal Cancer Management Posted by By Mourabit Halima 2025.06.30
CLDN18.2 Microenvironment Characteristics and Precision Treatment Progress Posted by By Mourabit Halima 2025.06.30
Professor Niels van de Donk: Four Key Advantages of the Trispecific Antibody JNJ-5322 in R/R MM Posted by By Mourabit Halima 2025.06.28
